Fig. 8From: HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomasKnockdown of HMG20A enhanced cisplatin sensitivity, and inhibited DNA damage repair, proliferation and invasion of OSCC cells. A, cell viability of BHY and HSC3 cells transfected with si-HMG20A or si-NC at different cisplatin concentrations. B, IC50 to cisplatin of BHY and HSC3 cells transfected with si-HMG20A or si-NC. C, BHY and HSC3 cells transfected with si-HMG20A or si-NC were treated with 5 µM cisplatin for 48 h. Western blotting was used to measure the protein levels of ERCC1 and γ-H2AX. β-actin was the internal control. D/E, BHY and HSC3 cells transfected with si-HMG20A or si-NC were treated with 5 µM cisplatin for 48 h. CCK8 and Transwell assay was used to detect cell proliferation (D) and invasion (E). **P < 0.01, si-HMG20A group vs. si-NC groupBack to article page